Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

85% Probability Of FDA Approval For Dynavax's Heplisav, Says Cowen's Senior Analyst
Seeking Alpha
Thursday, October 25, 2012 - 11:01am
tags:
FDA, Heplisav, Dynavax Technologies, hepatitis B
Medicines Company 3Q profit down, revenue up
Yahoo/AP
Thursday, October 25, 2012 - 10:57am
tags:
earnings, Medicines Company
Abbott: A 'Must Buy' Pharma For Long-Term Gains
Seeking Alpha
Thursday, October 25, 2012 - 10:56am
tags:
Abbott Labs, Humira
This Big Biotech Rejoices, but for How Long?
Motley Fool
Thursday, October 25, 2012 - 10:55am
tags:
Gilead
Sanofi earnings slump in Q3 as competition heats up
Yahoo/AP
Thursday, October 25, 2012 - 10:53am
tags:
earnings, Sanofi
[video]An Early Christmas for Flu Vaccine Companies?
Motley Fool
Thursday, October 25, 2012 - 10:51am
tags:
Flu, vaccines
Swiss drug maker Novartis posts 3Q profits virtually unchanged from a year ago
Yahoo/AP
Thursday, October 25, 2012 - 10:50am
tags:
earnings, Novartis
AstraZeneca Profit Beats Estimates; Forecast Unchanged
Bloomberg
Thursday, October 25, 2012 - 10:48am
tags:
earnings, AstraZeneca
Hormone therapy may cut Alzheimer's risk in menopausal women
Reuters
Thursday, October 25, 2012 - 10:48am
tags:
Alzheimer's disease, HRT
A Post-Lipitor Pfizer: Financial Projection And Stock Valuation
Seeking Alpha
Thursday, October 25, 2012 - 10:47am
tags:
Pfizer, earnings, generics, Lipitor
Detailed data supports Actelion's big lung drug hope
Reuters
Wednesday, October 24, 2012 - 12:05pm
tags:
Actelion, macitentan, PAH
What's Left For Threshold? Not Much
Seeking Alpha
Wednesday, October 24, 2012 - 12:00pm
tags:
Threshold Pharmaceuticals, TH-302
Questcor Earnings: Knocking It Out of the Park
Motley Fool
Wednesday, October 24, 2012 - 11:56am
tags:
earnings, Questcor
Regeneron posts strong 3rd-quarter results on new approvals; raises Eylea sales estimate
Yahoo/AP
Wednesday, October 24, 2012 - 11:55am
tags:
earnings, Regeneron
Spectrum Pharma: Guessing Q3 Fusilev Sales
TheStreet.com
Wednesday, October 24, 2012 - 11:54am
tags:
Spectrum Pharmaceuticals, earnings
Alexion Pharma 3rd-quarter net income rises on broader Soliris approval and settlement
Yahoo/AP
Wednesday, October 24, 2012 - 11:53am
tags:
Alexion, earnings
Q3 biotech venture investing makes a boisterous leap
Fierce Biotech
Wednesday, October 24, 2012 - 11:53am
tags:
venture capital, biotech
Lupin eyes 15 new drug launches in US by March 2013
Economic Times, India
Wednesday, October 24, 2012 - 11:46am
tags:
India, Lupin
Teva reports Phase III study results of Quartette contraceptive
The Fly on the Wall
Wednesday, October 24, 2012 - 11:44am
tags:
Teva, Quartette, birth control pill, contraceptives
United Therapeutics Falls as FDA Rejects Oral Remodulin
Bloomberg
Wednesday, October 24, 2012 - 11:43am
tags:
FDA, Remodulin, United Therapeutics, PAH

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.